Clinical Trials Directory

Trials / Completed

CompletedNCT05240378

Mortality of Cancer Surgery During SARS CoV2 Pandemic

Preoperative Screening for COVID-19 and Strict COVID Cancer Protocol Helps to Reduce Postoperative Infection, Mortality and Morbidity in Cancer Patients Undergoing Surgery. A Comparative Study

Status
Completed
Phase
Study type
Observational
Enrollment
1,576 (actual)
Sponsor
Banaras Hindu University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers

Summary

The impact of cancer surgery during covid epidemic is not clear. The published reports show contradictory findings that extend from no change in mortality to increased mortality, further no data on exposure and outcome of health care worker is available. This study is designed to address the above questions

Detailed description

This is a retrospective study from the prospectively collected data that is extracted from the electronic database of Department of Surgical Oncology, IMS, BHU The data is inform of two cohorts one extending from April 2019-April 2020 and other from May 2020 to May 2021 i.e. pre covid and during covid pandemic

Conditions

Interventions

TypeNameDescription
OTHERSurgerySurgery for cancer as per the stage of the disease and protocol

Timeline

Start date
2021-10-29
Primary completion
2021-12-31
Completion
2022-01-15
First posted
2022-02-15
Last updated
2022-03-03

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT05240378. Inclusion in this directory is not an endorsement.